Author: Publisher:
ISBN:
Category :
Languages : en
Pages : 98
Book Description
106-2 Hearing: Patient Access To Self-Injectable Prescription Drugs In The Medicare Program, Serial No. 106-122, March 23, 2000
Author: 106-2 Hearing: Patient Access to Self-Injectable Prescription Drugs in the Medicare Program, Serial
Author: 106-2 Hearing: Patient Access To Self-Injectable Prescription Drugs In The Medicare Program, Serial No. 106-122, March 23, 2000
Author: Patient Access to Self-injectable Prescription Drugs in the Medicare Program
Author: United States. Congress. House. Committee on Commerce. Subcommittee on Health and the EnvironmentPublisher:
ISBN:
Category : Drug accessibility
Languages : en
Pages : 88
Book Description
PATIENT ACCESS TO SELF-INJECTABLE PRESCRIPTION DRUGS IN THE..., HEARING... SERIAL NO. 106-122... COMMITTEE ON COMMERCE, HOUSE OF REPRESENTAT.
Author: United States. Congress. House. Committee on CommercePublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Report on the Activity of the Committee on Commerce for the One Hundred Sixth Congress
Author: United States. Congress. House. Committee on CommercePublisher:
ISBN:
Category :
Languages : en
Pages : 368
Book Description
Patient Access to Self-Injectable Prescription Drugs in the Medicare Program
Author: Michael BilirakisPublisher:
ISBN: 9780756716301
Category :
Languages : en
Pages : 70
Book Description
Witnesses: Nancy Ennis-Davenport, founding Executive Director, Patient Advocate Foundation; Michael Hash, Deputy Administrator, Health Care Financing Administration (HCFA); Rosalie Lohrman; Mariellen Rybicki; Julie Sizemore; Earl P. Steinberg; & Jane A. Story.
Legislative Calendar
Author: United States. Congress. House. Committee on CommercePublisher:
ISBN:
Category : Government publications
Languages : en
Pages : 674
Book Description
The CMS Hospital Conditions of Participation and Interpretive Guidelines
Author: Publisher:
ISBN: 9781683086857
Category :
Languages : en
Pages : 546
Book Description
In addition to reprinting the PDF of the CMS CoPs and Interpretive Guidelines, we include key Survey and Certification memos that CMS has issued to announced changes to the emergency preparedness final rule, fire and smoke door annual testing requirements, survey team composition and investigation of complaints, infection control screenings, and legionella risk reduction.
Registries for Evaluating Patient Outcomes
Author: Agency for Healthcare Research and Quality/AHRQPublisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385
Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.